Hospital-based evidence on cost-effectiveness of brucellosis diagnostic tests and treatment in Kenyan hospitals
Hospitals in Kenya continue to use the Febrile Antigen Brucella Agglutination Test (FBAT) to diagnose brucellosis, despite reports showing its inadequacy. This study generated hospital-based evidence on the performance and cost-effectiveness of the FBAT, compared to the Rose Bengal Test (RBT).Twelve...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Journal Article |
| Language: | Inglés |
| Published: |
Public Library of Science
2021
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10568/110774 |
Similar Items: Hospital-based evidence on cost-effectiveness of brucellosis diagnostic tests and treatment in Kenyan hospitals
- Poor performance of the rapid test for human brucellosis in health facilities in Kenya
- Molecular screening reveals non-uniform malaria transmission in western Kenya and absence of Rickettsia africae and selected arboviruses in hospital patients
- Fluorescence Polarization Assay (FPA): rapid diagnostic field test for brucellosis in ruminants in low-resource settings and tropic conditions like Cote d'Ivoire
- Spatial epidemiology of hospital-diagnosed brucellosis in Kampala, Uganda
- Human brucellosis in febrile patients seeking treatment at remote hospitals, northeastern Kenya, 2014–2015
- Epidemiology of brucellosis at the human-livestock interface in Uganda